Biopreservation Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented by Products (Biopreservation Media, Equipment), Application Area (Biobanking, Regenerative Medicine, Drug Discovery, Others), End-User, and Geography

Market Snapshot

Biopreservation Market_Image 1
Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

15.3%

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

Global Biopreservation market is expected witness a CAGR of 15.3% during the forecast period. Certain factors that are driving the market growth include improving healthcare expenditure, adoption of in-house sample storage in hospitals and labs, and increasing R&D investment.

Healthcare expenditure continues to increase faster than economic growth in most countries, maintaining a trend observed over decades. The presence of equitable, responsive, and efficient health systems across North America, Europe, and Asia-Pacific has also contributed to the maximum possible share of GDP being utilized for healthcare expenditure. Biopreservation has broad public health and socio-economic impacts, and is affecting many lives across the world. It has been widely used to preserve cells and tissues, targeting its applications in reproductive medicine and organ transplantation. Stem cell banking and gene banking have also gained global popularity. With growing healthcare expenditure each year, there is growing government collaboration with companies and universities for better exposure to the technology used and its development for higher efficiency, with approval rate of a product in the market. With growing technological advancements in biopreservation and healthcare equipment, along with cost effectiveness of these instruments, a major share of healthcare spending is going to be invested this domain.

However, concerns with the transition from laboratory to the market include the major problems of preservation and storage of tissues or cells. Despite the protection, the processes of freezing and thawing often causes tissue damage or cell injury. This factor hinders the growth of the market potential of biopreservation. Tissue cryopreservation is highly complicated and difficult than cryopreservation of individual cells. Injury to cells during freezing and thawing are related to the physicochemical and biophysical changes occurring during cryopreservation.

Scope of the Report

Biopreservation is a process that helps store biological samples for a longer period. Cells, tissues, plasma, and others are some of the common biological samples preserved through biopreservation.

Products
Biopreservation Media
Equipment
Temperature Maintaining Units
Consumables
Others
Application Area
Biobanking
Regenerative Medicine
Drug Discovery
Others
End User
Biobanks
Hospitals
Others
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Biopreservation Media is Expected to Hold Significant Market Share in the Product Type Segment

Nutrient media has found wide application in stem cell therapy and transplanted organ preservation. Tissue engineering, which includes stem cell storage, has seen prominent usage of nutrient media. Early stage of stem cell culture depends on continuous supply of oxygen and nutrition diffusion. Stem cell engineering has been widely used for treating bone defects. Nutrient media has also been used exclusively for organ preservation and organ transportation. The most common approaches for organ preservation during an organ transplant are simple static cold storage (SCS) and hypothermic machine perfusion (HMP). They are approved for transplantation of liver, lungs, pancreas, heart, and kidney.

Biopreservation Market_Image 2

To understand key trends, Download Sample Report

North America Dominates the Market and Expected to do Same in the Forecasted Period

The North America market is primarily driven by the rise in demand for preservation of blood, solid tissue specimen, including paraffin-embedded or frozen bio-specimen of tumors, and other tissues, peripheral blood cells and bone marrow, along with stem cells-derived cord blood and its derivatives, across multiple research institutes, pathological centers, and hospitals. Favorable government regulations have also been observed in the country, which are supporting the sharing of biological samples.

Biopreservation Market_Image 3

To understand geography trends, Download Sample Report

Competitive Landscape

The global Biopreservationmarket is highly competitive and consists of a number of major players. Companies like BioCision LLC, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd, Custom Biogenic Systems Inc., Lifeline Scientific Inc., Merck KGaA, Princeton CryoTech Inc., VWR International, among others, hold the substantial market share in the Biopreservation market.

Major Players

  1. BioLife Solutions Inc.
  2. Cesca Therapeutics Inc.
  3. Lifeline Scientific Inc.
  4. Merck KGaA
  5. BioCision LLC

* Complete list of players covered available in the table of contents below

Biopreservation Market_Image 4

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Improving Healthcare Expenditure

      2. 4.2.2 Adoption of In-House Sample Storage in Hospitals and Labs

      3. 4.2.3 Increasing R&D Investment

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of the Instruments and its Maintenance

      2. 4.3.2 Possibility of Tissue Injury During Preservation and Thawing

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Products

      1. 5.1.1 Biopreservation Media

      2. 5.1.2 Equipment

        1. 5.1.2.1 Temperature Maintaining Units

        2. 5.1.2.2 Consumables

        3. 5.1.2.3 Others

    2. 5.2 Application Area

      1. 5.2.1 Biobanking

      2. 5.2.2 Regenerative Medicine

      3. 5.2.3 Drug Discovery

      4. 5.2.4 Others

    3. 5.3 End User

      1. 5.3.1 Biobanks

      2. 5.3.2 Hospitals

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 US

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 UK

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 BioCision LLC

      2. 6.1.2 BioLife Solutions Inc.

      3. 6.1.3 Cesca Therapeutics Inc.

      4. 6.1.4 Core Dynamics Ltd

      5. 6.1.5 Custom Biogenic Systems Inc.

      6. 6.1.6 Lifeline Scientific Inc.

      7. 6.1.7 Merck KGaA

      8. 6.1.8 Princeton CryoTech Inc.

      9. 6.1.9 VWR International

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information